CD155 promotes radioresistance and malignancy of esophageal cancer by regulating Hippo-YAP pathway

The expression of CD155 has been observed to increase in various human cancers, but its role in the development of esophageal cancer (EC) is unclear. Radiotherapy is one of the primary therapeutic options for EC. However, radioresistance is still a severe issue in EC treatment. In this study, Oncomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Huixian, Liu, Yuchen, Chen, Pengxiang, Yin, Tianwen, Wang, Meijie, Liu, Tianyu, Wen, Zhihua, Cheng, Yufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243211/
https://www.ncbi.nlm.nih.gov/pubmed/35768666
http://dx.doi.org/10.1007/s12672-022-00515-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243211/
https://www.ncbi.nlm.nih.gov/pubmed/35768666
http://dx.doi.org/10.1007/s12672-022-00515-z

Ejemplares similares